News
-
-
PRESS RELEASE
Symrise delivered solid organic sales growth and strong profitability improvement for 2025
Symrise AG reported solid organic sales growth of 2.8% and improved profitability for 2025, with an adjusted EBITDA margin of 21.9%. Updated capital allocation priorities include a €400 million share buyback and 16th consecutive dividend increase -
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.
Symrise AG decides to divest its terpenes business, resulting in a non-cash impairment for the investment in Swedencare AB. Advanced talks with potential buyers ongoing -
-